Clinical Trial Update: Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ruxolitinib in combination with chemotherapy for adolescents and young adults with Philadelphia-like acute lymphoblastic leuke…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: University of Chicago | Conditions: Acute Lymphoblastic Leukemia, ALL, Childhood | Phase 1 | Status: RECRUITING